Connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonia: Similarity and difference

Seminars in Ultrasound, CT and MRI

Volumn 35, Issue 1, 2014, Pages 29-38

  Bryson, Thomas ^a   Sundaram, Baskaran ^a   Khanna, Dinesh ^b   Kazerooni, Ella A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD VESSEL INJURY; CELLULAR IMMUNITY; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; ECHOCARDIOGRAPHY; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; INTERSTITIAL PNEUMONIA; LUNG FUNCTION TEST; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROLOGY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ARTHRITIS, RHEUMATOID; CONNECTIVE TISSUE DISEASES; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; LUNG DISEASES, INTERSTITIAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIXED CONNECTIVE TISSUE DISEASE; MYOSITIS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892997726     PISSN: 08872171     EISSN: 15585034     Source Type: Journal    
DOI: 10.1053/j.sult.2013.10.010     Document Type: Article

References (80)

1. Cottin V. Interstitial lung disease: Are we missing formes frustes of connective tissue diseaseα. Eur Respir J 2006, 28(5):893-896.
2. Fischer A., West S.G., Swigris J.J., et al. Connective tissue disease-associated interstitial lung disease: A call for clarification. Chest 2010, 138(2):251-256.
3. Mittoo S., Gelber A.C., Christopher-Stine L., et al. Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med 2009, 103(8):1152-1158.
4. de Lauretis A., Veeraraghavan S., Renzoni E. Review series: Aspects of interstitial lung disease: Connective tissue disease-associated interstitial lung disease: How does it differ from IPFα How should the clinical approach differα. Chron Respir Dis 2011, 8(1):53-82.
5. Coral-Alvarado P., Pardo A.L., Castano-Rodriguez N., et al. Systemic sclerosis: A world wide global analysis. Clin Rheumatol 2009, 28(7):757-765.
6. Steen V.D., Medsger T.A. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007, 66(7):940-944.
7. Steen V., Domsic R.T., Lucas M., et al. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis Rheum 2012, 64(9):2986-2994.
8. Launay D., Remy-Jardin M., Michon-Pasturel U., et al. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 2006, 33(9):1789-1801.
9. Devenyi K., Czirjak L. High resolution computed tomography for the evaluation of lung involvement in 101 patients with scleroderma. Clin Rheumatol 1995, 14(6):633-640.
10. Bouros D., Wells A.U., Nicholson A.G., et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002, 165(12):1581-1586.
11. Silva C.I., Muller N.L. Interstitial lung disease in the setting of collagen vascular disease. Semin Roentgenol 2010, 45(1):22-28.
12. Goh N.S., Desai S.R., Veeraraghavan S., et al. Interstitial lung disease in systemic sclerosis: A simple staging system. Am J Respir Crit Care Med 2008, 177(11):1248-1254.
13. Shah R.M., Jimenez S., Wechsler R. Significance of ground-glass opacity on HRCT in long-term follow-up of patients with systemic sclerosis. J Thorac Imaging 2007, 22(2):120-124.
14. Capobianco J., Grimberg A., Thompson B.M., et al. Thoracic manifestations of collagen vascular diseases. Radiographics 2012, 32(1):33-50.
15. Grosse C., Grosse A.C.T. findings in diseases associated with pulmonary hypertension: A current review. Radiographics 2010, 30(7):1753-1777.
16. Wells A.U., Steen V., Valentini G. Pulmonary complications: One of the most challenging complications of systemic sclerosis. Rheumatology (Oxford) 2009, 48(suppl 3):iii40-iii44.
17. Condliffe R., Radon M., Hurdman J., et al. CT pulmonary angiography combined with echocardiography in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology (Oxford) 2011, 50(8):1480-1486.
18. Pandey A.K., Wilcox P., Mayo J.R., et al. Predictors of pulmonary hypertension on high-resolution computed tomography of the chest in systemic sclerosis: A retrospective analysis. Can Assoc Radiol J 2010, 61(5):291-296.
19. Goldin J.G., Lynch D.A., Strollo D.C., et al. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 2008, 134(2):358-367.
20. Goldin J., Elashoff R., Kim H.J., et al. Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: Findings from the scleroderma lung study. Chest 2009, 136(5):1333-1340.
21. Khanna D., Tseng C.H., Farmani N., et al. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group. Arthritis Rheum 2011, 63(10):3078-3085.
22. Kim D.S. Interstitial lung disease in rheumatoid arthritis: Recent advances. Curr Opin Pulm Med 2006, 12(5):346-353.
23. Gabriel S.E. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001, 27(2):269-281.
24. Nannini C., Ryu J.H., Matteson E.L. Lung disease in rheumatoid arthritis. Curr Opin Rheumatol 2008, 20(3):340-346.
25. Mori S., Cho I., Koga Y., et al. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 2008, 35(8):1513-1521.
26. Mori S., Koga Y., Sugimoto M. Small airway obstruction in patients with rheumatoid arthritis. Mod Rheumatol 2011, 21(2):164-173.
27. Bongartz T., Nannini C., Medina-Velasquez Y.F., et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study. Arthritis Rheum 2010, 62(6):1583-1591.
28. Olson A.L., Swigris J.J., Sprunger D.B., et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 2011, 183(3):372-378.
29. Tsuchiya Y., Takayanagi N., Sugiura H., et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 2011, 37(6):1411-1417.
30. Mori S., Koga Y., Sugimoto M. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med 2012, 106(11):1591-1599.
31. Lee H.K., Kim D.S., Yoo B., et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005, 127(6):2019-2027.
32. Kim E.J., Collard H.R., King T.E. Rheumatoid arthritis-associated interstitial lung disease: The relevance of histopathologic and radiographic pattern. Chest 2009, 136(5):1397-1405.
33. Tanaka N., Kim J.S., Newell J.D., et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004, 232(1):81-91.
34. Kim E.J., Elicker B.M., Maldonado F., et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010, 35(6):1322-1328.
35. Tanoue L.T. Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med 1998, 19(4):667-685. [viii].
36. Franquet T. High-resolution CT of lung disease related to collagen vascular disease. Radiol Clin North Am 2001, 39(6):1171-1187.
37. Pons-Estel G.J., Alarcon G.S., Scofield L., et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010, 39(4):257-268.
38. Allen D., Fischer A., Bshouty Z., et al. Evaluating systemic lupus erythematosus patients for lung involvement. Lupus 2012, 21(12):1316-1325.
39. Jurencak R., Fritzler M., Tyrrell P., et al. Autoantibodies in pediatric systemic lupus erythematosus: Ethnic grouping, cluster analysis, and clinical correlations. J Rheumatol 2009, 36(2):416-421.
40. Mittoo S., Gelber A.C., Hitchon C.A., et al. Clinical and serologic factors associated with lupus pleuritis. J Rheumatol 2010, 37(4):747-753.
41. Kinder B.W., Freemer M.M., King T.E., et al. Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. Arthritis Rheum 2007, 56(8):2679-2686.
42. Bernatsky S., Boivin J.F., Joseph L., et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006, 54(8):2550-2557.
43. Cheema G.S., Quismorio F.P. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med 2000, 6(5):424-429.
44. Matthay R.A., Schwarz M.I., Petty T.L., et al. Pulmonary manifestations of systemic lupus erythematosus: Review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975, 54(5):397-409.
45. Karim M.Y., Miranda L.C., Tench C.M., et al. Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. Semin Arthritis Rheum 2002, 31(5):289-298.
46. Fenlon H.M., Doran M., Sant S.M., et al. High-resolution chest CT in systemic lupus erythematosus. Am J Roentgenol 1996, 166(2):301-307.
47. Sant S.M., Doran M., Fenelon H.M., et al. Pleuropulmonary abnormalities in patients with systemic lupus erythematosus: Assessment with high resolution computed tomography, chest radiography and pulmonary function tests. Clin Exp Rheumatol 1997, 15(5):507-513.
48. Ooi G.C., Ngan H., Peh W.C., et al. Systemic lupus erythematosus patients with respiratory symptoms: The value of HRCT. Clin Radiol 1997, 52(10):775-781.
49. Good J.T., King T.E., Antony V.B., et al. Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983, 84(6):714-718.
50. Porcel J.M., Ordi-Ros J., Esquerda A., et al. Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis. Lupus 2007, 16(1):25-27.
51. Fathi M., Vikgren J., Boijsen M., et al. Interstitial lung disease in polymyositis and dermatomyositis: Longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 2008, 59(5):677-685.
52. Dalakas M.C., Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003, 362(9388):971-982.
53. Marguerie C., Bunn C.C., Beynon H.L., et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990, 77(282):1019-1038.
54. Solomon J., Swigris J.J., Brown K.K. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol 2011, 37(1):100-109.
55. Koreeda Y., Higashimoto I., Yamamoto M., et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med 2010, 49(5):361-369.
56. Fathi M., Dastmalchi M., Rasmussen E., et al. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004, 63(3):297-301.
57. Tansey D., Wells A.U., Colby T.V., et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004, 44(6):585-596.
58. Kim S.J., Lee K.S., Ryu Y.H., et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: Diagnostic implications. Am J Roentgenol 2003, 180(5):1251-1254.
59. Fischer A., Swigris J.J., du Bois R.M., et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med 2009, 103(11):1719-1724.
60. Lundberg I.E. The heart in dermatomyositis and polymyositis. Rheumatology (Oxford) 2006, 45(suppl 4). iv18-21.
61. Hill C.L., Zhang Y., Sigurgeirsson B., et al. Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet 2001, 357(9250):96-100.
62. Gunnarsson R., Aalokken T.M., Molberg O., et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: A nationwide, cross-sectional study. Ann Rheum Dis 2012, 71(12):1966-1972.
63. Bodolay E., Szekanecz Z., Devenyi K., et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) 2005, 44(5):656-661.
64. Burdt M.A., Hoffman R.W., Deutscher S.L., et al. Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings. Arthritis Rheum 1999, 42(5):899-909.
65. Kozuka T., Johkoh T., Honda O., et al. Pulmonary involvement in mixed connective tissue disease: High-resolution CT findings in 41 patients. J Thorac Imaging 2001, 16(2):94-98.
66. Saito Y., Terada M., Takada T., et al. Pulmonary involvement in mixed connective tissue disease: Comparison with other collagen vascular diseases using high resolution CT. J Comput Assist Tomogr 2002, 26(3):349-357.
67. Dalvi V., Gonzalez E.B., Lovett L. Lymphocytic interstitial pneumonitis (LIP) in Sjogren's syndrome: A case report and a review of the literature. Clin Rheumatol 2007, 26(8):1339-1343.
68. Ramos-Casals M., Solans R., Rosas J., et al. Primary Sjogren syndrome in Spain: Clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008, 87(4):210-219.
69. Lohrmann C., Uhl M., Warnatz K., et al. High-resolution CT imaging of the lung for patients with primary Sjogren's syndrome. Eur J Radiol 2004, 52(2):137-143.
70. Ito I., Nagai S., Kitaichi M., et al. Pulmonary manifestations of primary Sjogren's syndrome: A clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005, 171(6):632-638.
71. Parambil J.G., Myers J.L., Lindell R.M., et al. Interstitial lung disease in primary Sjogren syndrome. Chest 2006, 130(5):1489-1495.
72. Voulgarelis M., Dafni U.G., Isenberg D.A., et al. Malignant lymphoma in primary Sjogren's syndrome: A multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's Syndrome. Arthritis Rheum 1999, 42(8):1765-1772.
73. Tonami H., Matoba M., Kuginuki Y., et al. Clinical and imaging findings of lymphoma in patients with Sjogren syndrome. J Comput Assist Tomogr 2003, 27(4):517-524.
74. Honda O., Johkoh T., Ichikado K., et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. Am J Roentgenol 1999, 173(1):71-74.
75. Song J.W., Do K.H., Kim M.Y., et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009, 136(1):23-30.
76. Raghu G., Collard H.R., Egan J.J., et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183(6):788-824.
77. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002, 165(2):277-304. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.
78. Thomeer M.J., Vansteenkiste J., Verbeken E.K., et al. Interstitial lung diseases: Characteristics at diagnosis and mortality risk assessment. Respir Med 2004, 98(6):567-573.
79. Park J.H., Kim D.S., Park I.N., et al. Prognosis of fibrotic interstitial pneumonia: Idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007, 175(7):705-711.
80. Castelino F.V., Varga J. Interstitial lung disease in connective tissue diseases: Evolving concepts of pathogenesis and management. Arthritis Res Ther 2010, 12(4):213.